DiaMedica Therapeutics Inc.
DMAC
$3.53
-$0.01-0.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 44.15M | 50.20M | 54.06M | 46.52M | 52.90M |
| Total Receivables | 236.00K | 290.00K | 391.00K | 399.00K | 369.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 227.00K | 280.00K | 568.00K | 569.00K | 411.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 44.61M | 50.77M | 55.01M | 47.48M | 53.68M |
|
|
|||||
| Total Current Assets | 44.61M | 50.77M | 55.01M | 47.48M | 53.68M |
| Net Property, Plant & Equipment | 427.00K | 449.00K | 469.00K | 468.00K | 485.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.31M | 1.31M | 1.31M | 1.31M | -- |
| Total Assets | 46.35M | 52.52M | 56.79M | 49.26M | 54.16M |
|
|
|||||
| Total Accounts Payable | 940.00K | 1.17M | 759.00K | 716.00K | 926.00K |
| Total Accrued Expenses | 4.35M | 3.02M | 2.23M | 1.82M | 1.78M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 103.00K | 102.00K | 100.00K | 86.00K | 83.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.39M | 4.30M | 3.09M | 2.62M | 2.79M |
|
|
|||||
| Total Current Liabilities | 5.39M | 4.30M | 3.09M | 2.62M | 2.79M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 237.00K | 263.00K | 288.00K | 294.00K | 317.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.63M | 4.56M | 3.38M | 2.91M | 3.10M |
|
|
|||||
| Common Stock & APIC | 180.70M | 179.99M | 179.29M | 167.10M | 166.61M |
| Retained Earnings | -140.00M | -132.10M | -125.83M | -120.71M | -115.56M |
| Treasury Stock & Other | 23.00K | 81.00K | -51.00K | -39.00K | 6.00K |
| Total Common Equity | 40.72M | 47.96M | 53.42M | 46.35M | 51.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 40.72M | 47.96M | 53.42M | 46.35M | 51.06M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 40.72M | 47.96M | 53.42M | 46.35M | 51.06M |
|
|
|||||